Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline
about
The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic ReviewTranslational research in nephrology: chronic kidney disease prevention and public healthThe Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent YearsAging, diabetes, and the public health system in the United StatesDiabetic nephropathy and extracellular matrixDiabetic kidney disease: a report from an ADA Consensus ConferenceDiabetic kidney disease: from physiology to therapeuticsC-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?Trends in breast cancer incidence rates by age and tumor characteristics of women in the city of Isfahan for the period 2001-2010: An application of joinpoint analysisInflammation in diabetic kidney diseasePrevalence of diabetic retinopathy in the United States, 2005-2008.Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patientsEffect of intrauterine diabetes exposure on the incidence of end-stage renal disease in young adults with type 2 diabetesPancreas transplantation in type II diabetes mellitus.Application of joinpoint regression in determining breast cancer incidence rate change points by age and tumor characteristics in women aged 30-69 (years) and in Isfahan city from 2001 to 2010.Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3.Diabetes performance measures: current status and future directions.Susceptibility gene search for nephropathy and related traits in Mexican-Americans.Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathyDeclining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008Microvascular disease precedes the decline in renal function in the streptozotocin-induced diabetic rat.Diabetic Kidney Disease: Much Progress, But Still More to DoHypertension Management in Diabetic Kidney DiseasePreventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program.Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey.Optimizing care in diabetes: a quixotic challenge.Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney diseaseDiabetic nephropathy: What does the future hold?Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift.Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT)The effect of intradialytic aerobic exercise on dialysis efficacy in hemodialysis patients: a randomized controlled trialImpact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure.Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.Risk for end-stage renal disease over 25 years in the population-based WESDR cohort.Complications and characteristics of patients referred to a joint diabetes renal clinic in Ireland.The renal endothelium in diabetic nephropathy.Diabetic kidney disease in Australia: current burden and future projections.Transplant options for patients with type 2 diabetes and chronic kidney disease.Novel effective drugs for diabetic kidney disease? or not?
P2860
Q26774377-AECDD234-ED7D-459D-87AF-1DBC8EB7C4E0Q26776395-1F13A498-4B4A-4E9F-AFD1-53306145D925Q26799468-C72B2AD3-3834-4E6B-8306-F75B1331512BQ26852929-EE63EEAB-F44D-4292-B663-610564ECAA9DQ26996008-5FA7D3B3-47E5-46D3-88A7-7EB05D2C306BQ27012546-E04AA067-2141-4302-B9AE-BC61E6D5F899Q27021392-8AB666CE-CE9D-4A70-A3A4-FFBCD8856B34Q33620560-93F28DF1-491F-48D2-8CA8-E7DE5EC2673FQ33953983-E49BBC92-CEB5-42E1-9910-AAB429172FF8Q33971017-270B22AB-8BF4-492D-B259-798EA434FD45Q34023543-7FF7C7A8-7F22-4CFA-9765-4BB42F3B74B5Q34154127-3B469E1F-4E86-4A76-B794-CA16C4AB6804Q34168451-B91347D0-D566-4431-BC00-5797EEFA853CQ34237403-6C7174F5-11DF-493C-A4AB-DC6F75360F5DQ34761327-A2B88A9B-16F9-4CFF-89B7-2B82838EAEFBQ34767244-8BED91B2-0505-4C6F-8551-538F37282013Q35047036-D7A364DB-9564-400C-9208-D557A9799F3CQ35060223-1A00AC06-0B5A-4AAF-B096-031A34413DC3Q35101768-320E7051-5BAA-4673-AFE5-592F5D1BEA97Q35673446-5B5B22D9-FCBD-47C4-A43F-EED2183DB5B4Q35688229-E75AB712-21BC-4F9A-B311-9B05D985FD79Q35780734-8ED53857-EC60-42D2-98E3-F115F7AC2650Q35953872-9E01FA9B-B643-41A9-A8FB-AC1A27F2CB71Q35953909-A28FFB94-421C-49D6-B02D-E3D51BDCBB57Q35964467-7EE87E4C-6D6D-4400-BC48-97160F83CB19Q35976508-699EFB0F-4B67-45BB-A99F-0782D0473EB4Q35976546-B79CC4AA-62F1-454E-9A8E-E8DA3EA4FCF9Q35995060-3F36E129-21DC-45B0-98F1-7066882EB886Q36441616-EB88963C-CFBE-4314-92AE-3B6476462D6AQ36796216-FDEA2239-9D99-4584-A218-82FB3720F3F8Q37151933-843BD6BB-A136-47F2-9BDF-7D11405002C2Q37160502-DB112E69-B7FA-4A0F-A4EB-3CD10C42F2B5Q37204873-7DBF34C0-98BC-4AA6-A645-958C6DF9B173Q37333543-76321520-7BDB-4873-9BF7-16DAAC27B491Q37504054-7FCAA900-D34E-48C5-8C51-592F36A9BC5AQ37998946-10BC1B52-8ABE-4866-9F99-9AF1795AAB7AQ38087656-648BC4FC-A459-4A55-9401-17C28BB5864FQ38216851-166146A5-A59B-4ED4-9FE7-A106C2ADE8CCQ38230451-FAC805D7-F503-4355-B7BA-9C130C52492CQ38265818-0423D790-4275-42C6-8FC1-04924AB341DA
P2860
Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Incidence of treatment for end ...... the U.S. continues to decline
@ast
Incidence of treatment for end ...... the U.S. continues to decline
@en
Incidence of treatment for end ...... the U.S. continues to decline.
@nl
type
label
Incidence of treatment for end ...... the U.S. continues to decline
@ast
Incidence of treatment for end ...... the U.S. continues to decline
@en
Incidence of treatment for end ...... the U.S. continues to decline.
@nl
prefLabel
Incidence of treatment for end ...... the U.S. continues to decline
@ast
Incidence of treatment for end ...... the U.S. continues to decline
@en
Incidence of treatment for end ...... the U.S. continues to decline.
@nl
P2860
P356
P1433
P1476
Incidence of treatment for end ...... the U.S. continues to decline
@en
P2093
Nilka Ríos Burrows
Yanfeng Li
P2860
P356
10.2337/DC09-0343
P407
P577
2010-01-01T00:00:00Z